Monday's ETF Movers: XBI, QCLN. 2401 Millstream Rd 125 Victoria BC. Looking at the chart above, XBI's low point in its 52 week range is $62. ETF Summary. AMGN. LABU has a lower 5-year return than XBI (-46. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 64 billion, a PE ratio of 11. Find the latest iShares Biotechnology ETF (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. The XBI is a modified equally weighted index and includes many well known mid-cap stocks with momentum that are likely to move up in a sector rally. In addition to holding 155 positions, its top 10 holdings make up just 14. The 10 largest holdings have a combined 17. Market On Millstream The. Cryptocurrency. Stocks. Holding Companies. by Morningstar Manager Research. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. Top 10 Holdings. 79 in February 2021 and has fallen over (50%) to $76. com. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . XBI has traded between $62. More XBI Holdings Current Portfolio Date Nov 20, 2023; Equity Holdings 132; Bond Holdings 0; Other Holdings 3 % Assets in Top 10 Holdings 16. 18. 64 per share, with $174. 97. XBI Price: 68. 250-590-1718. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 1 Day NAV Change as of Nov 09, 2023. 12% in the last one year (as. Also includes news, ETF details and other investing information. XBI has a beta of 1. Across the 192 current stocks in the fund, all holdings have a weighting between 0. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. 45% and is down about -9. SPDR S&P Biotech ETF ETF holdings by MarketWatch. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the XBI: SPDR S&P. News, commentary and events are from third-party sources unaffiliated with Fidelity. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. Currency in USD Follow 2W 10W 9M 73. SPDR® S&P Biotech ETF XBI. Performance and Risk The ETF has lost about -29. Sector ETFs. Cryptocurrency. 00%) Most Recent Dividend 0. 97. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. 97. For an ETF, this widget displays the top 10 constituents that make up the fund. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. Below is the comparison between FBT and XBI. View and export this data back to 2006. 12% in the last one year (as of 03/16/2023). Fund Size Comparison. At midday the XBI is rebounding indicating there is buying interest near $101. The most heavily invested institutionals were Morgan Stanley ($614. 97. A few losers won't cause XBI to crash. In addition, the recent spike in volatility has increased option prices even. The index is equal-weighted so that smaller biotech stocks can make it into the portfolio. $0. 81 and $97. Staples:. Plus view geographic exposure, currency. 81 and $134. News & World Report, XBI. Net Expense Ratio. The sale of ETFs is subject to an activity assessment fee (from $0. ETF Strategies. View complete IBB exchange traded fund holdings for. The beaten-down prices offer a solid buying opportunity for investors. The. 15 billion assets under management. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. by Sweta Killa Published on September 18,2023. (XBI) SPDR S&P Biotech ETF Stock Price, Holdings,. FBT has a higher expense ratio than XBI (0. N/A. Below is the comparison between VHT and XBI. The Global X Nasdaq 100 Covered Call ETF (QYLD) follows a “covered call” or “buy-write” strategy, in which the Fund buys the stocks in the Nasdaq 100 Index and “writes” or “sells” corresponding call options on the same index. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. All 142 XBI Holdings. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. 4% of the stocks in our database. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 2013. 58%: Halozyme Therapeutics Inc:XLY News. 66% so far this year and in the past. Performance and Risk. •. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. The Health category average is 45. 88 ; Annual Dividend & Yield 0. 78% so far this year and in the past one year (as of 11/20/2023), respectively. IMVT. The top holding in XBI receives just a 1. Dividend ETFs. Most recent portfolio value is calculated to be $ 7,141,224,184 USD. Real Estate ETFs. 3. (“SSGA FM” or the “Adviser”), the investment adviser to the Fund, either may invest the Fund's assets. 66 +2. The gross expense ratio is the fund’s total annual operating expenses ratio. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. underlying holdings of the fund. The top 10 holdings account for about 11. 1% and 1. 61%) At close: 04:00PM EST Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. 86 Prior Close 70. 24 per unit, that means that analysts see 75. 78% of XBI's total assets under management. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style, stock holdings and more. 60 as the 52 week high point — that compares with a last trade of $77. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. SPDR S&P Biotech ETF. Meanwhile, XBI equal weights its holdings. The main reason for this is the additional risk mitigation an ETF provides given its myriad holdings within a sector. Before you invest in the SPDR ® S&P Biotech ETF (the “Fund”), you may want to review the Fund's prospectus and statement of additional information, which contain more information about the Fund and the risks of investing in the Fund. Skip to main content. 48%: Number of Holdings 78: Price/Book Ratio Price/Book Ratio. 58%). Wix. 54%. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). LABU. Site search Search. XBI has traded between $62. For investors that want to rely on modern portfolio theory rather than assessing biotechnology companies, this is a solid option. XBI focuses on health care investments and follows the S&P Biotech Index. *Close price adjusted for splits. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. 0. Its top 10 holdings account for approximately 16. XBI's top 10 holdings account for about 14. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 96 on December 31, 2021, to $83 per share at the end of 2022. Holdings: 136: Inception Date: Jan 31, 2006: About XBI Fund Home Page The SPDR S&P BIOTECH ETF (XBI) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. Its top 10 holdings account for approximately 16. 95. XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar. 9%. 2. Components of. m. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. 50% vs. 53 (+3. Stocks. 1. Message board - Online Community of active, educated investors researching and discussing Novavax Inc. 0. ARGX. 02%. While IBB has many more holdings than XBI (376 vs. Netherlands. 2% weight, and there are 133 holdings in total in the fund (Figure 1). Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). This large ETF has performed well and is at its year highs, but will it continue to outperform? With takeover activity occurring in the sector, how will this ETF benefit? How is this ETF. ETF Channel Staff - Friday, October 20, 6:48 AM. 11. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Check out the side-by-side comparison table of IBB vs. GrowthStrategy: Traditional growth investing is an investment. 12 and $91. Latest SPDR® S&P Biotech ETF (XBI:PCQ:USD) share price with interactive charts, historical prices, comparative analysis, forecasts,. 5. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Thu, Nov 9, 1:16 PM ET, Market News Video. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. 5. Additionally. 33% so far, and is up roughly 4. 07. Chart. 50 down to $98. Themes & Subsectors ETFs. **Close price adjusted for splits and dividend and/or capital gain distributions. 58. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p. 84% for the trailing three-year period, which makes the fund a high risk choice in the space. Comparing the most. The fund’s NAV was $81. Its top 10 holdings account for approximately 16. 57 billion. 94 per share, with $121. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). Across the 192 current stocks in the fund, all holdings have a weighting between 0. BIIB is also in the top 15 XBI holdings. February 15, 2023 — 10:47 am EST. 50 -0. One of the ideas making the rounds on Wall Street right now (I’ve seen it commented on in a number of places) is buying XBI, the SPDR S&P Biotech ETF, at this time of year, for a spring rally. View the top holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI). Jun 8, 2022 10:51AM EDT. Looking at the chart above, XBI's low point in its 52 week range is $100. 35%. 83%: Other: 0. Free ratings, analyses, holdings, benchmarks, quotes, and news. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. I have thoroughly reviewed the holdings of the XBI and have come away impressed with how broad-based the composition of the ETF is. Looking at the chart above, XBI's low point in its 52 week range is $62. XBI has an overall POWR Rating of D, equating to a Sell. 47% vs -5. XLV. The ETF has a beta of 1. 86% so far this year and is down about -32. 06 a share on Wednesday which marked its lowest level dating back to June 30 of 2022. The weighted harmonic average of closing market price divided by. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. In its most recent earnings release, President and Chief Executive Officer Christopher A. XBI ETF's holdings offer significant diversification. Analysis of these related ETFs and how they are trading may provide insight to this commodity. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. Holdings. 64 billion, a PE ratio of 11. Meanwhile, XBI equal weights its holdings. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. 8 million shares. 32% of the total portfolio assets. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. 70% so far this year and is down about -16. And, again, it is in the top 15 holdings by weighting of the. Cash and Equivalents. Written by BNK Invest for BNK Invest ->. 66%. The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). Check out the side-by-side comparison table of XBI vs. 87. ETFs are subject to market fluctuation and the risks of their underlying investments. Reply Like (7) q. We daily evaluate future near-term price gain prospects for quality, market-seasoned ETFs, based on the expectations of market. 45% vs 0. 2 %. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Free ratings, analyses, holdings, benchmarks, quotes, and news. Neena Mishra May 10, 2023. 1%). 04%. Top 10 Holdings. 2% Top Ten Holdings. Index Dividend Yield The weighted average of the underlyings’ indicated annual dividend A high-level overview of SPDR® S&P Biotech ETF (XBI) stock. While I love Cathie Wood, I just don't see how she can keep this up. According to 9 analysts, the average rating for IMGN stock is "Strong Buy. 23%) Advertisement SPDR S&P Biotech ETF (XBI) NYSEArca - NYSEArca Delayed Price. 04 per unit, that means that analysts see 73. 91 (11/14/23) 1 Day XBI 0. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. WisdomTree Cloud Computing Fund ETF holdings by MarketWatch. 07. Looking at the chart above, XBI's low point in its 52 week range is $63. Research performance, expense ratio, holdings, and volatility to see if it's the. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. Sector Exposure and Top Holdings. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. XBI vs BBH. Royal Gold Inc. Performance and Risk. 19%. LABD. Fund Analysis. Below is the comparison between VHT and XBI. Notable ETF Outflow Detected - XBI, CYTK, CCXI, SRPT. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. XLV comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. $0. The top 10 holdings account for about 11. Free ratings, analyses, holdings, benchmarks, quotes, and news. 40 for Nov. 15 per share, with $174. 01 %IBB: iShares Biotechnology ETF: 0. Diversification. The table below compares many ETF metrics between IBB and XBI. The top ten holdings in IBB make up 51% of the fund, while the top ten in XBI only account for 12% of the fund. IBB outperformed the S&P 500 last year and did much better than XBI. 6738M. SPDR® S&P Biotech ETF. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. VICTORIA, BC / ACCESSWIRE / September 27, 2023 / Boron One Holdings Inc. 17% for the trailing three-year period, which makes XBI a high. Performance and Risk. Top 10 Holdings (14. Both LABU and XBI are ETFs. It can be found in the fund’s most recent prospectus. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. The index and exchange-traded fund ETF are rebalanced four times a year. 78% of XBI's total assets under management. 35% Expense Ratio 20 40 60 per page Viewing 1-20 of 134 matches 1 2 3 4 5 XBI: SPDR S&P Biotech ETF - Fund Holdings. 97% in the last one year (as of 11/07/2022). XBI comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. The weighted harmonic average of closing market price divided by. 1. 84. 61%) At close: 04:00PM ESTSeeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. 78%) has been the biggest winner, with its shares jumping nearly 40% year to date. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. 98 and standard deviation of 40. 6% of the fund. 19%. XBI, BEAM, FATE, NTLA: ETF Outflow Alert. 01 per share, with $174. The following charts reflect the geographic spread of WCLD's underlying holdings. Expense ratio and liquidity are average for the group. -listed equities in the biotechnology sector. IBB vs. No company usually makes up more than two percent of. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. While this ETF allocates. 1% vs 0. Here, we set out to define in detail the pharmacokinetics of a well-characterized IDR molecule, IDR-1018. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 78% of XBI's total assets under management. ETF Channel Staff - Friday, October 20, 6:48 AM. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 89%. XBI is an almost pure play on the biotechnology sector. 73. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Name Symbol % Assets. ETFs - IBB, PBE, XBI. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. 64 per share, with $174. Performance and Risk The ETF has lost about -9. 99% upside for this ETF looking through to the average analyst targets of the underlying holdings. 22% of total assets) As of November 16, 2023. argenx SE ADR. 86% so far this year and is down about -32. S. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 70% so far this year and is down about -16. XBI. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. XBI holdings. 1% and 1. NBI IBBQ XBI BTK FBT IBB Other Topics Indexes Stocks ETFs Coronavirus Prableen Bajpai Prableen Bajpai is the founder of FinFix Research and. Find Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) top 10 holdings and sector breakdown by %. Twin City Holdings Ltd. 98 and standard deviation of 37. 54%. Looking at the chart above, XBI's low point in its 52 week range is $100. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and trend lines. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF. DLTR. Top 10 Holdings (14. ETFs are subject to market fluctuation and the risks of their underlying investments. View the XBI funds market news. Top 10 Holdings XBI. 58 💸. 01%). The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. XBI, whose index recently expanded, also owns only a handful of established biotech companies. The firm has a market cap of $5. Historical Price Data. XBI's top 10 holdings account for about 11. 01% vs 8. View Holdings As of 09/30/2023. Looking at the chart above, XBI's low point in its 52 week range is $62. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 86% so far this year and is down about -32.